4.7 Review

Strategies for controlled delivery of growth factors and cells for bone regeneration

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 64, Issue 12, Pages 1292-1309

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2012.01.016

Keywords

Bone tissue engineering; Controlled delivery; Growth factors; Cells; Scaffolds

Funding

  1. National Institutes of Health (NIH) [R01 DE17441, R01 AR57083, R01 AR48756]
  2. National Institutes of Health

Ask authors/readers for more resources

The controlled delivery of growth factors and cells within biomaterial carriers can enhance and accelerate functional bone formation. The carrier system can be designed with pre-programmed release kinetics to deliver bioactive molecules in a localized, spatiotemporal manner most similar to the natural wound healing process. The carrier can also act as an extracellular matrix-mimicking substrate for promoting osteoprogenitor cellular infiltration and proliferation for integrative tissue repair. This review discusses the role of various regenerative factors involved in bone healing and their appropriate combinations with different delivery systems for augmenting bone regeneration. The general requirements of protein, cell and gene therapy are described, with elaboration on how the selection of materials, configurations and processing affects growth factor and cell delivery and regenerative efficacy in both in vitro and in vivo applications for bone tissue engineering. (C) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available